List of insiders holdings for AVADEL PHARMACEUTICALS PLC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| KOTLER KEVIN Broadfin Capital LLC Broadfin Healthcare Master Fund Ltd Director | 2020-02-13 17:26:45 | 1,029,012 0 | 1,029,012 | Form 13G |
| THOMPSON PHILLANDAS T. See Remarks | 2019-03-11 19:16:08 | 688,671 0 | 688,671 | Form 4 |
| Seurer Jerad G. Gen. Counsel & Corp. Secretary | 2024-05-03 16:30:05 | 416,295 0 | 416,295 | Form 3 |
| KANAN MICHAEL F See Remarks | 2019-03-11 19:10:54 | 410,538 0 | 410,538 | Form 4 |
| DUBOW JORDAN Chief Medical Officer | 2019-04-30 17:51:39 | 340,000 0 | 340,000 | Form 4 |
| Williamson Douglas J Chief Medical Officer | 2022-02-16 16:40:17 | 275,000 0 | 275,000 | Form 4 |
| MONTEITH DAVID See Remarks | 2017-10-11 16:28:39 | 252,500 0 | 252,500 | Form 4 |
| MACKE SCOTT A. See Remarks | 2017-10-11 16:27:33 | 233,500 0 | 233,500 | Form 4 |
| DAVIS GREGORY J. See Remarks | 2017-10-11 16:25:22 | 195,000 0 | 195,000 | Form 4 |
| Ende Eric J Director | 2024-08-01 16:36:12 | 189,900 0 | 189,900 | Form 4 |
| CERUTTI GUILLAUME See Remarks | 2017-06-30 16:17:54 | 183,440 0 | 183,440 | Form 4 |
| NAVARRE CHRISTOPHE See Remarks | 2018-07-20 16:08:47 | 169,417 0 | 169,417 | Form 4 |
| VAN ASSCHE BENOIT See Remarks | 2018-07-20 16:11:57 | 169,417 0 | 169,417 | Form 4 |
| Divis Gregory J Chief Executive Officer | 2024-12-10 18:14:56 | 159,100 10,000 | 169,100 | Form 4 |
| FILDES FRANCIS See Remarks | 2018-07-20 16:07:19 | 150,859 0 | 150,859 | Form 4 |
| Vaughn Jason Sr. VP, Technical Operations | 2019-11-14 17:11:10 | 150,000 0 | 150,000 | Form 4 |
| Kim Richard J Chief Commercial Officer | 2024-03-04 06:28:57 | 147,000 0 | 147,000 | Form 4 |
| D'SILVA DHIREN VP Irish & European Operations | 2018-02-07 16:06:26 | 145,000 0 | 145,000 | Form 4 |
| Elrod Marcus W See Remarks | 2017-10-11 16:26:28 | 125,400 0 | 125,400 | Form 4 |
| SULLIVAN STEPHEN G. See Remarks | 2017-10-11 16:29:48 | 125,000 0 | 125,000 | Form 4 |
| Thornton Peter J. Director | 2024-08-01 16:37:19 | 105,055 0 | 105,055 | Form 4 |
| McCamish Mark Anthony Director | 2024-08-01 16:32:04 | 22,000 67,025 | 89,025 | Form 4 |
| MCHUGH THOMAS S Chief Financial Officer | 2024-12-16 07:00:09 | 87,800 0 | 87,800 | Form 4 |
| Glass Geoffrey Michael Director | 2024-12-10 18:13:59 | 11,000 75,904 | 86,904 | Form 4 |
| Hatten Sandra L See Remarks | 2019-12-16 16:21:11 | 55,765 3,400 | 59,165 | Form 4 |
| Palczuk Linda Director | 2024-12-19 16:20:43 | 25,000 0 | 25,000 | Form 4 |
| Amin Naseem Director | 2024-08-01 16:35:13 | 22,000 0 | 22,000 | Form 4 |
| NOHRA GUY P See Footnotes | 2003-10-03 17:46:28 | 0 6,443 | 6,443 | Form 4 |
| GUSKY DAVID P See Remarks | 2019-07-05 16:05:44 | 0 0 | 0 | Form 4 |
| STAPLETON CRAIG R Director | 2019-05-10 16:46:30 | 0 0 | 0 | Form 4 |
| ANDERSON MICHAEL S See Remarks | 2019-01-18 16:09:19 | 0 0 | 0 | Form 4 |
| Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Private Design Fund II L.P. Deerfield Special Situations Fund L.P. Deerfield Mgmt L.P. Deerfield Private Design International II L.P. Breaking Stick Holdings LLC *Possible member of 10% group 10% Owner | 2020-02-13 12:38:41 | 0 0 | 0 | Form 13G |
| ALTA PARTNERS ALTA BIOPHARMA PARTNERS LP ALTA BIOPHARMA MANAGEMENT LLC ALTA EMBARCADERO BIOPHARMA PARTNERS LLC ALTA CHASE BIOPHARMA MANAGEMENT LLC FLAMEL CHASE PARTNERS ALTA BIO LLC DELEAGE JEAN GRUENER GARRETT JANNEY DANIEL MARDUEL ALIX 10% Owner | 2003-10-09 17:18:49 | 0 0 | 0 | Form 13D |